Next-step program for young children with preschool wheeze
Part of Lungs & breathing clinical trials.
This study supports children ages 2–6 who have been diagnosed with preschool wheeze and need regular lung follow-up. It checks a “next step” approach for managing symptoms in children who already use inhaler medicine and have had recent wheezing episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is age 2 to 6 and has a doctor’s diagnosis of preschool wheeze
- Your child has had respiratory symptoms needing planned pediatric follow-up for at least 1 year
- Your child uses inhaler medicine regularly, including inhaled steroid medicine
- Your child has had either (a) 3 wheezing episodes treated by healthcare professionals (with at least one seen by a pediatrician in the past 12 months) or (b) at least 1 hospital admission for lung/respiratory symptoms
- Parents or caregivers can give consent and understand the study in Dutch and can use a smartphone/internet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at young children (ages 1-5) who have had severe wheezing episodes that needed hospital care. It aims to find biomarkers (clues in the body) that could help predict which children might develop asthma later.
This study tests whether a bacterial “lysate” medicine, given to preterm babies, can reduce respiratory (lung) infections and wheezing. It may help protect babies’ airways during the vulnerable first months after birth.
This study looks at different kinds of wheezing in young children (ages 1 to 5) to better understand what causes it and how to treat it. If your child has had wheezing more than once, this research could help find patterns that lead to better care.
This study tests if giving oral steroids (medicine to reduce airway swelling) only when needed based on a child's own biology can help preschool children with wheezing. It aims to find the best treatment for each child, avoiding unnecessary medicine.
This study looks at how the gut and lungs affect breathing problems in children. It compares samples from children with and without respiratory illnesses to understand why some children get sicker than others.
This study tests if the medicine Dupilumab can help control asthma and wheezing in children ages 2 to just under 6. It is for children whose symptoms are not well-managed with their current inhaler.
Hear when a new eHealth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.